Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 2/20 | 0.58 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | VNN1 | O95497 | 1/20 | 0.40 |
| ▸ | F10 | P00742 | 2/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 8/20 | 0.38 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.38 |
| ▸ | FASN | P49327 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6833717 | 0.92 | ALB (0.60) | ALBSERPINE1MEN1KMT2AL3MBTL1 | |
| SCHEMBL6830657 | 0.91 | ALB (0.59) | ALBSERPINE1MEN1KMT2AL3MBTL1 | |
| SCHEMBL6830668 | 0.86 | SERPINE1 (0.47) | ALBSERPINE1MEN1KMT2ANPC1 | |
| SCHEMBL6834265 | 0.81 | ALB (0.67) | ALBSERPINE1MEN1KMT2AL3MBTL1 | |
| SCHEMBL6835734 | 0.81 | ALB (0.63) | ALBSERPINE1MEN1KMT2AL3MBTL1 | |
| Hydrochloric Acid SCHEMBL6834033 | 0.80 | ALB (0.65) | ALBSERPINE1MEN1KMT2AL3MBTL1 | |
| SCHEMBL6818554 | 0.78 | ALB (0.63) | ALBFASN | |
| Hydrochloric Acid SCHEMBL6821748 | 0.78 | ALB (0.70) | ALBMEN1KMT2AL3MBTL1F10 | |
| SCHEMBL6833781 | 0.77 | ALB (0.64) | ALBMEN1KMT2AL3MBTL1F10 | |
| SCHEMBL6833065 | 0.76 | ALB (0.61) | ALBMEN1KMT2AL3MBTL1F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | ALB 1417/4885SERPINE1 1860/4885MEN1 4132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.